Growing skin in a dish for wound repair/hair restoration, some research to read

IDW2BB

Established Member
Reaction score
19
Title says it all, I added some quotes I found interesting, these are free full text:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684595/: Induction of anagen hairs in host animals as well as the more advanced stage of neofollicles adjacent to the wound edge suggests the plausible involvement of the wound-induced environment and hair growth. It is also possible that ingrowth of nerve fibers from the wound edge may promote maturation of nascent hair follicles.
http://www.jci.org/articles/view/57414: In general, hair follicles develop de novo only during embryonic development, and new hair follicles do not form in postnatal skin. Therefore, skin diseases that result in loss of the HFSC compartment or of the entire follicle lead to permanent hair loss. Despite largely anecdotal data, the existence of de novo hair follicle regeneration in adult mammals was debated and essentially discounted (4548). However, recent evidence has illuminated the potential for adult skin to regenerate entire skin appendages in vivo. Hair follicle regeneration following repair of large full-thickness wounds was definitively demonstrated in adult mice (49). In that study, nascent hair follicles displayed similar morphological and biochemical changes as those observed during embryonic hair development (49). In essence, hair follicle neogenesis represents a rare example of amphibian-like organ regeneration in mammals and demonstrates that embryonic developmental programs may be recapitulated in adult skin during wound healing.
In the study by Ito et al. (49), K15[SUP]+[/SUP] bulge-derived follicular cells did not significantly contribute to nascent hair follicles, although neogenic hair follicles generated new HFSCs that allowed them to cycle independently of surrounding follicles in intact skin. This suggests that neogenic follicles may be derived from either normally unipotent epidermal basal cells and/or another hair follicle population outside of the bulge/sHG. Lgr6[SUP]+[/SUP] cells represent a specific population of cells that reside within the isthmus above the bulge and contribute to the sebaceous gland and epidermis during homeostasis (24). Similar to K15-derived bulge cells, Lgr6-labeled cells mobilize to the epidermis following wounding. These Lgr6-derived cells were shown to durably contribute to wound-induced neogenic hair follicles, suggesting that some hair follicle cells can serve as precursors for neogenic hair follicles and neogenic HFSCs.
http://www.nature.com/jid/journal/v116/n2/full/5600973a.html : Sensory nerve fibers contain neuropeptides synthesized in the cell body that are transported in vesicles to the peripheral nerve ending ([SUP]Tausk et al. 1993[/SUP]). Neuropeptides exert a number of efferent functions, such as the modulation of blood flow, glandular activity, and inflammatory skin responses ([SUP]Tausk et al. 1993;Maggi, 1995;Ansel et al. 1997[/SUP]).
Recently, there has been increasing interest in so-called ''trophic functions'' of skin innervation ([SUP]Maggi, 1995;Paus et al. 1995,1997[/SUP]), e.g., in wound healing ([SUP]Tausk et al. 1993;Ansel et al. 1997[/SUP]) or in the maintenance of various epithelial structures such as epidermis, taste buds, and epidermal ridges ([SUP]Lundberg et al. 1979;Morohunfola et al. 1992;Li et al. 1997;Botchkarev et al. 1999[/SUP]). In this context, several observations have suggested a role for sensory nerve fibers in hair growth control ([SUP]Hordinsky & Ericson, 1996;Paus et al. 1997[/SUP]). As one of the most densely innervated organs of the mammalian body (Figure 1) ([SUP]Rice & Munger, 1986;Winkelmann, 1988;Botchkarev et al. 1997b;Fundin et al. 1997[/SUP]), the hair follicle thus offers an intriguing model system for dissecting the piloneural interactions that are likely to underlie the ''trophic'' effects of neuropeptides ([SUP]Paus et al. 1997[/SUP])
http://www.nature.com/cddis/journal/v4/n7/full/cddis2013249a.html : It appears that the organotypic 3D human skin-melanoma spheroid model developed here provides an environment that more closely resembles the physiology of human malignant melanoma than previously available systems and may therefore set milestones for the study and understanding of this malignancy.
The environment of melanoma in patients is, however, even more complex; besides tumor-associated fibroblast, the microenvironment of human melanoma comprises various other non-transformed cell types, including immune cells and endothelial cells. The skin-melanoma spheroid model will serve as a basis for constructing models that integrate additional cell types present in the melanoma microenvironment, and may also be suitable to host other types of cancer. Therapeutically, the 3D skin-melanoma spheroid model will be useful for short-term screening of primary melanoma cells freshly isolated from patients. One can envisage the inclusion of spheroids derived from primary human melanoma (Supplementary Figure S5) or even of pieces of melanoma metastases. Thereby, preclinical testing of therapeutic combinations in the context of a known genetic make-up of a given melanoma (e.g., BRAF mutation) would be enabled, paving the path to more personalized approaches in melanoma therapy. In this context, an increasing complexity of the model will offer a useful platform to study the impact of soluble factors, like cytokines or RTK ligands released from tumor cells or surrounding host cells, that have been shown to influence the therapeutic outcome of melanoma.[SUP]<!--bib38-->38[/SUP]
Including the organotypic 3D skin-melanoma model into the preclinical testing repertoire is likely to provide that only the most promising novel therapeutic concepts are taken forward into clinical testing so that, in the future, the attrition rate of potential new treatments for this disease may be reduced and their rate of success in clinical trials increased
http://www.jove.com/video/2937/the-three-dimensional-human-skin-reconstruct-model-tool-to-study:
Using viral vectors, we are able to either activate or inactivate gene function for a better understanding of the dynamics and functional significance of genes expressed by each cell type in skin reconstructs, which promises to be an efficient model to study not only transformation mechanisms of melanocytes, but also progression of melanoma (8). Long-term observation of cell phenotypes has become possible through grafting of skin reconstructs to immunodeficient animals. Such a human skin-mouse chimera is an excellent research tool to study melanomagenesis and melanoma metastasis.
Skin reconstructs can also be a useful platform for drug assessment. Many drugs which eradicate cancer cells in 2D culture conditions often have little effect in experimental and clinical applications. As seen in the in vivo tumor, melanoma cells in 3D cultures are often resistant to the drugs which cells in 2D cultures respond to, suggesting that the microenvironment modulates signaling pathways in melanoma. For successful drug discovery, the 3D skin reconstruct model is an ideal preclinical tool to predict the effects of compounds in vivo (9,10).
In summary, skin reconstruct models bridge the gap between in vitro and in vivo studies. They will lead to a better understanding of which genes are involved in transformation and how stem cells contribute to that transformation.

- - - Updated - - -

http://www.jove.com/video/4344/rapid-genetic-analysis-epithelial-mesenchymal-signaling-during-hair check out the video

- - - Updated - - -

Title says it all, I added some quotes I found interesting, these are free full text:

- - - Updated - - -

http://www.jove.com/video/4344/rapid-genetic-analysis-epithelial-mesenchymal-signaling-during-hair check out the video

and the latest by Cot's : http://www.nature.com/jid/journal/vaop/naam/abs/jid2013337a.html
 
Last edited:

squeegee

Banned
Reaction score
132
So this is your plan Idontwanttobebalding? :)
 

IDW2BB

Established Member
Reaction score
19
Perhaps my future grandchildren or great grandchildren will benefit from this but not me. I think the possibility to activate or deactivate certain genes in a dish will help find a cure for male pattern baldness. Should be able to safely test new drugs on these hairs as well as delivery vehicles. About the only thing anybody can do now is to try and save what they got!
 

IDW2BB

Established Member
Reaction score
19
Took a step closer today.

http://www.nature.com/news/cultured-follicles-offer-hope-for-beating-baldness-1.13983


But yet......Armando strikes again!


excerpt from the link:


He adds that the latest work is exciting, even though the hair produced is “not yet ready for prime time”. The new follicles did not always produce a hair through the skin, and they lacked pigment and sebaceous oil glands. Christiano says that it will be some time before those kinks are ironed out and the method is ready for the clinic.

- - - Updated - - -

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625575/


In recent years, a variety of techniques have been developed to engineer tissues composed only of cells and the matrix materials that they secrete without any exogenous scaffold materials. Such techniques are even being applied for tissues where scaffolds have shown success (e.g., skin, bone, and cartilage) [18]. Scaffold-free cell sheet-based constructs have been applied for tissue repair due to their high rates of nutrient diffusion, abundant deposition of ECM, and interactions with cell membrane proteins, including growth factors, ion channels, and cell-to-cell junction proteins. Ascorbic acid has been reported to induce telomerase activity, leading to upregulation of type I collagen, fibronectin, and integrin β1. Ascorbic acid-treated mesenchymal cells form sheets due to increased ECM production. Furthermore, Lee et al. constructed a dermal equivalent from fibroblasts treated with ascorbic acid without other exogenous materials [19]. Based on this paper, we cocultured 3 types of cells (keratinocytes, dermal fibroblasts, and dermal microvascular endothelial cells) to form scaffold-free skin equivalents containing capillary-like networks. The cocultured cells expressed high levels of vascularization-associated growth factors, including VEGF, bFGF, and PDGF, compared to cocultures of fibroblasts and endothelial cells and monocultures.
 

IDW2BB

Established Member
Reaction score
19
these last 2 links are really interesting when both are considered together.



http://www.nature.com/jid/journal/v133/n11/full/jid2013387a.html

In an effort to overcome some of the inherent OCS limitations, such as inefficient tissue perfusion, the so-called “on-a-chipâ€￾ approaches are starting to emerge. Through integration of microfluidic technologies, on-a-chip approaches deliver a constant steady-state flow of culture medium to tissues. Additionally, bioengineering techniques that can reconstitute endothelial microvascular tissue networks in vitro are now being developed. When these networks are allowed to anastomose to the preengineered microfluidic channels, this approach can support in vivo–like perfusion and physical scaling of OCS size, which currently is largely limited by the inefficiency of passive diffusion (Sakaguchi et al., 2013).

- - - Updated - - -

http://www.nature.com/srep/2013/130219/srep01316/full/srep01316.html

In vitro scaling up of bioengineered tissues is known to be limited by diffusion issues, specifically a lack of vasculature. Here, we report a new strategy for preserving cell viability in three-dimensional tissues using cell sheet technology and a perfusion bioreactor having collagen-based microchannels. When triple-layer cardiac cell sheets are incubated within this bioreactor, endothelial cells in the cell sheets migrate to vascularize in the collagen gel, and finally connect with the microchannels. Medium readily flows into the cell sheets through the microchannels and the newly developed capillaries, while the cardiac construct shows simultaneous beating. When additional triple-layer cell sheets are repeatedly layered, new multi-layer construct spontaneously integrates and the resulting construct becomes a vascularized thick tissue. These results confirmed our method to fabricate in vitro vascularized tissue surrogates that overcomes engineered-tissue thickness limitations. The surrogates promise new therapies for damaged organs as well as new in vitro tissue models.


free article that combines well with the ones just posted.
 
Top